Lendalizumab (Anti-Complement C5)
Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2847 |
| Sku # | A2847-1mg*25 |
| Pricing | 1mg*25, $5070.00 |